In good agreement, PVT1 is negatively correlated with miR-152 expression in tumors from gastric cancer patients, and its genetic manipulation in SGC7901 and BGC823 gastric cell lines influences miR-152 levels and ultimately, CD151 and FGF2 expression (60). The gene discussed is FGF2; the disease is gastric cancer.